This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The healthcare mergers and acquisitions (M&A) market began 2025 with a slower start than expected given the easing headwinds and building momentum at the end of last year, with the number of deals reported in Q1 lower than the number of deals reported in the same period last year.
A variety of factors are expected to significantly increase Canadian M&A activity in 2025. We expect to enter 2025 with some positive momentum in Canadian dealmaking.
2025 promises a dynamic and challenging year for businesses as key antitrust cases set new precedent, private antitrust litigation will intensify, and legal battles evolve.
On January 10, 2025, the Federal Trade Commission (the FTC) announced that it will (i) increase the dollar-based thresholds used to determine whether parties are required to notify federal antitrust authorities about a transaction under the Hart-Scott-Rodino Antitrust Improvements Act (HSR) and (ii) revise the HSR filing fee schedule.
As the global markets look towards 2025, a dynamic evolution is anticipated within the landscape of mergers and acquisitions (M&A). Key strategic drivers such as regulatory adjustments, monetary policy normalizations, and technological advancements are set to steer the course of M&A activities.
Sheppard Mullin partners, Cyrus Abbassi and Leonard Lipsky, served as panelists at the annual Orthopedics Today Conference in Kauai, Hawaii, held in January 2025. During a spirited discussion with various stakeholders in the orthopedics industry, they noted the following key takeaways: 1.
Read our latest insights into the U.S. private equity market. We cover monthly deal activity and size, fundraising, exits, leveraged loans, and a look ahead. The drop in March deal count pushed Q1 deal count to the lowest quarterly level since the onset of the pandemic in Q2 2020.
Here are the ones worth watching in 2025. The Ankura Healthcare Real Estate Strategy team monitors a wide variety of economic indicators to inform clients upcoming strategic endeavors. By: Ankura
A Recap: Expectations for 2025 Versus Reality to Date - 2025 began with optimism that mergers and acquisitions (M&A) activity would continue to increase this year.
As an avid Red Sox fan and former Los Angeles resident who often attended Dodgers games, I may still be basking in the Yankees’ loss in the World Series. Whatever the reason, I can’t help but draw parallels between the game of baseball and the world of M&A.
on April 24, 2025 to discuss new enforcement policies and share updates on current issues in antitrust. Antitrust experts from across the globe convened in Washington, D.C.
The latest edition of Directors Quarterly features a summary of board and committee agenda priorities for 2025, financial reporting and auditing updates, post-election observations from around the world, and more. Read the insights now. By: KPMG Board Leadership Center (BLC)
Tax developments - Pillar 2s viability: Perspectives from industry leaders - In a prior edition of Tax Bytes, we explained how some, including the Finance Ministers of Hungary and India, have questioned the viability of Pillar 2.
SPECIAL EUROPEAN COUNCIL - Main results of the Special European Council - 06 March 2025. European Council conclusions on European defence. By: Mayer Brown
In 2024, in line with our predictions from last year, the UK public takeover market saw a sharp increase in the number of megadeals, i.e., those valued in excess of 1 billion. Seventeen such transactions were announced in 2024, which is over four times as many in 2023.
Trends to Watch in 2025 January 7, 2025 As we welcome 2025, Wilson Sonsini litigators shed light on the emerging trends and key issues they see shaping the legal landscape, from AI regulation to evolving trade secret laws and increasing scrutiny on corporate disclosures. By: Wilson Sonsini Goodrich & Rosati
The KPMG Board Leadership Center has published its annual message for directors that highlights nine issues for boards to keep in mind as they consider and carry out their 2025 agendas. By: KPMG Board Leadership Center (BLC)
Here are our predictions for 2025. Our commercial insight and understanding of the market environment place us in a unique position to comment on M&A trends. By: DLA Piper
1-23-108, banned most non-compete agreements for contracts signed on or after July 1, 2025, but with several meaningful exceptions. Wyoming, with the introduction of Wyo. By: Seyfarth Shaw LLP
Following the turn of the new year, our UK Regulatory specialists have examined the key regulatory developments in 2025 impacting a range of UK and European firms within the financial services sector. The key dates have been distilled by the Proskauer team in an easy to read timeline with our commentary. By: Proskauer Rose LLP
On January 3, 2025, Judge Paul R. 2025 WL 24364 (Del. Wallace of the Superior Court for the State of Delaware granted plaintiffs motion for summary judgment in a directors and officers (D&O) insurance denial case against. Harman Intl Indus. Illinois Natl Ins.
On January 10, 2025, the United States Federal Trade Commission (FTC) approved new premerger notification thresholds and revised filing fees under the Hart-Scott-Rodino Act (HSR). By: Jenner & Block
Brainwaves: 100 Days and Beyond | Presidential Policy Shifts Impacting Automotive: Foley & Lardner is excited to partner with the Society of Automotive Analysts to host an exclusive gathering of business and legal executives from the region for a timely program on March 11, 2025, at Foley & Lardners Detroit office.
As the healthcare industry heads into 2025, deals attorneys are optimistic as they look to falling interest rates and a potentially more business-friendly administration set to enter the White House. Originally published in Law360 - January 1, 2025. By: Latham & Watkins LLP
On January 7, 2025, Vice Chancellor Sam Glasscock III of the Delaware Court of Chancery issued a post-trial decision in favor of defendant, a private equity fund (the Fund), finding that the Funds sale of a portfolio company (the Company) was protected by the business judgment rule and did not harm the interests of minority stockholders.
UK CMA Imposes Fines for Information Exchanges Affecting Labour Markets - On 21 March 2025, the UK Competition and Markets Authority (CMA) announced fines on four UK broadcast and production companies for engaging in illegal exchanges of information. The case is the CMAs first competition law infringement decision concerning labour markets.
COMPETITION - Judgment of the Court of 13 February 2025 in Case C-393/23, Athenian Brewery SA, Heineken NV Vs. Macedonian Thrace Brewery SA Re: Reference for a preliminary ruling - Judicial cooperation in civil and commercial matters - Jurisdiction and the recognition and enforcement of judgments in civil and commercial matters.
PE dealmaking had a slower start in 2025. Read our latest insights into the U.S. private equity market. We cover monthly deal activity and size, fundraising, exits, leveraged loans, and a look ahead. YTD deal numbers through February were below those for the same period in the past five years. By: Ropes & Gray LLP
The life sciences industry is well positioned for growth in 2025, fueled by strong investor interest and technological advancements, especially in AI. Life sciences venture capital (VC) funding and IPOs have picked up in 2024, and anticipated Federal Reserve interest rate cuts will likely further accelerate this trend. By: Goodwin
N22C-05-098 PRW CCLD, 2025 WL 84702 (Del. 7, 2025), the court held the D&O policys bump-up exclusion was not a bar coverage. Indeed, in Harman International Industries, Inc. Illinois National Insurance Company, No. By: McCarter & English, LLP
Drawing on research, insights, and interactions with nom/gov committees and other board members, the KPMG Board Leadership Center highlights six issues for nom/gov committees to keep in mind as they consider their 2025 agendas. By: KPMG Board Leadership Center (BLC)
The Canadian government has increased the monetary thresholds to determine whether a net benefit review of a foreign investment in Canada is required under the Investment Canada Act for 2025. By: Stikeman Elliott LLP
As 2025 begins, the foreign direct investment (FDI) landscape continues to evolve at a rapid pace. As in previous years, we explore key developments that we expect will shape FDI screenings in 2025. As in previous years, we explore key developments that we expect will shape FDI screenings in 2025. By: Hogan Lovells
Moving into 2025, the dental industry faces a series of transformative shifts driven by evolving patient expectations, the rise of Dental Support Organizations (DSOs) and persistent operational challenges. The industry will need to make informed strategic decisions and overcome what could be a challenging year. By: Benesch
February 19, 2025: BlueDot Photonics, a developer of solar energy devices designed to improve solar panel performance and durability, was acquired by UbiQD, a development stage corporation, for an undisclosed amount. By: Mintz - Energy & Sustainability Viewpoints
On January 31, 2025, the U.S. With the FTC opting not to seek emergency relief from the Fifth Circuit, the deal closed on February 5, 2025. With the FTC opting not to seek emergency relief from the Fifth Circuit, the deal closed on February 5, 2025. mattress retailer with over 2,300 stores).
In an increasingly interconnected world, staying ahead of legal and regulatory developments across borders is critical. Our team of experienced attorneys advises on complex cross-border matters involving corporate transactions, regulatory compliance, intellectual property, tax, and dispute resolution. By: Potomac Law Group, PLLC
Welcome to the January 2025 issue of As the (Customs and Trade) World Turns, our monthly newsletter where we compile essential updates from the customs and trade world over the past month.
COMPETITION A refusal by an undertaking in a dominant position to ensure that its platform is interoperable with an app of another undertaking, which thereby becomes more attractive, can be abusive (See CPR N 19/2025 - Judgment of the Court of Justice in Case C-233/23,Alphabet and Others). By: Mayer Brown
The general consensus is that we will likely see an increase in M&A and capital market transactions in the life sciences sector in 2025. Cautious Optimism for Deal Making. By: Ballard Spahr LLP
On January 10, 2025, the Federal Trade Commissionannounced 2025 annual statutory adjustments to the Hart-Scott-Rodino Act thresholds. These thresholds determine which mergers and acquisitions must be reported to United States federal antitrust agencies for review before consummation. By: Fenwick & West LLP
On January 22, the Federal Trade Commission (FTC) published in the Federal Register its annual adjustments for notification thresholds regarding proposed mergers and acquisitions under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act), which will become effective 30 days after publication, on February 21. gross national product.
The Federal Trade Commission (FTC) announced on January 10, 2025 that it will raise the Hart-Scott-RodinoAct (HSR Act) jurisdictional and filing fee thresholds. The increased thresholds will go into effect 30 days after their forthcoming publication in the Federal Register. By: Morgan Lewis
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content